Your session is about to expire
← Back to Search
Chemotherapy for Biliary Tract Cancer
Study Summary
This trial is studying gemcitabine hydrochloride, cisplatin, and nab-paclitaxel to see how well they work in treating patients with biliary tract cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Arm II (cisplatin, gemcitabine hydrochloride)
- Group 2: Arm I (nab-paclitaxel, cisplatin, gemcitabine hydrochloride)
Frequently Asked Questions
Are there other examples in which Cisplatin has been used in a clinical setting?
"City of Hope Comprehensive Cancer Center was the first to study cisplatin in 1997. Since that time, there have been 2634 completed studies with 1636 more currently underway. Many of these live trials are being conducted in Redmond, Oregon."
Which medical facilities are currently conducting this research?
"There are 100 patients being recruited for this study from locations such as Saint Charles Health System-Redmond in Redmond, Baptist Memorial Hospital and Cancer Center-Union County in New Albany, and Cancer Treatment Centers of America in Tulsa, as well as 100 other locations."
Has Cisplatin been greenlit by the FDA?
"Cisplatin has received a score of 3 because there is both anecdotal and experimental evidence to support its efficacy, as well as extensive safety data."
What diseases has Cisplatin been shown to be most effective against?
"Cisplatin is often used as a treatment for neoplasm metastasis, but it can also help patients with acute pyelonephritis, shock, hypovolemic, and locally advanced non-small cell lung cancer."
Are there any current openings for people who want to enroll in this research project?
"Unfortunately, this particular study has already closed recruitment. The trial was originally posted on December 3, 2018 but was last edited on October 8, 2021. If you are looking for other studies, there are currently 2791 clinical trials actively searching for patients with intrahepatic cholangiocarcinoma and 1636 trials for Cisplatin actively searching for participants."
How many people total are participating in this experiment?
"This trial is not actively enrolling patients at the moment. The trial was initially posted on December 3rd, 2018 and was last updated on October 8th, 2021. If you are looking for other trials, there are 2791 trials related to intrahepatic cholangiocarcinoma and 1636 Cisplatin trials that are currently looking for participants."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger